C3 and rheumatoid arthritis: We demonstrated that one-half of anti-CCP+ RA patients possessed circulating (blood) ICs containing citrullinated fibrinogen, and that fibrinogen, immunoglobulin and complement component C3 co-localize in pannus tissue derived from RA patients.